Drug Res (Stuttg) 2015; 65(08): 398-402
DOI: 10.1055/s-0034-1375608
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Gabapentin Enhances Neurogenesis in E14 Rat Embryonic Neocortex Stem Cells

B. Paknejad
1   Department Toxicology-Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran
,
A. Kebriaeezadeh
1   Department Toxicology-Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran
,
M. H. Ghahremani
1   Department Toxicology-Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran
,
M. Gharghabi
1   Department Toxicology-Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran
,
S. N. Ostad
1   Department Toxicology-Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 24. Februar 2014

accepted 10. April 2014

Publikationsdatum:
30. Juli 2014 (online)

Preview

Abstract

Many anticonvulsant drugs have been studied for their non conventional therapeutic effects on neurodegerative diseases but merely a few demonstrated potential neurogenic characteristic. Gabapentin as a well-known mood stabilizer was studied for its potential capability to promote neurogenesis in embryonic rat cortical stem cells. Rat E14 cortical stem cells were exposed to gabapentin during differentiation for 7 days and subjected to immunocytochemistry. The phenotypic changes were evaluated in the ultimately survived and differentiated cells. Gabapentin (16 µg/ml) exposure significantly increased the number and percentage of MAP2 immunopositive neurons with no significant alterations in nestin or GFAP immunopositivity in neural or glial progenitors. The enhanced number of neurons by therapeutic doses of gabapentin via augmentation of the neuronal differentiation in neural stem cells may participate to the therapeutic properties of gabapentin in the treatment of mood disorder.